SPTLC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.117400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.710200E-01
Normal-vs-Stage2
4.832200E-01
Normal-vs-Stage3
2.342800E-01
Normal-vs-Stage4
2.388000E-01
Stage1-vs-Stage2
4.366800E-01
Stage1-vs-Stage3
1.221970E-01
Stage1-vs-Stage4
1.302630E-01
Stage2-vs-Stage3
5.073900E-02
Stage2-vs-Stage4
1.507640E-01
Stage3-vs-Stage4
4.272400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.361600E-01
Normal-vs-AfricanAmerican
9.274800E-01
Normal-vs-Asian
4.104600E-01
Caucasian-vs-AfricanAmerican
4.681000E-01
Caucasian-vs-Asian
3.294800E-01
AfricanAmerican-vs-Asian
3.174400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.639400E-01
Normal-vs-Female
4.525000E-01
Male-vs-Female
5.983800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.967200E-01
Normal-vs-Age(41-60Yrs)
2.208000E-01
Normal-vs-Age(61-80Yrs)
7.021000E-01
Normal-vs-Age(81-100Yrs)
7.311600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.602000E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.509000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.293200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.573900E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.252400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.044200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.153000E-01
Normal-vs-Daily Drinker
5.388200E-01
Normal-vs-Weekly Drinker
7.797600E-01
Normal-vs-Occasional Drinker
2.447000E-01
Normal-vs-Social Drinker
3.666200E-01
Non Drinker-vs-Daily Drinker
2.436000E-01
Non Drinker-vs-Weekly Drinker
8.463800E-01
Non Drinker-vs-Occasional Drinker
1.309840E-02
Non Drinker-vs-Social Drinker
1.841370E-01
Daily Drinker-vs-Weekly Drinker
3.795800E-01
Daily Drinker-vs-Occasional Drinker
1.780380E-01
Daily Drinker-vs-Social Drinker
8.702800E-01
Weekly Drinker-vs-Occasional Drinker
2.944500E-02
Weekly Drinker-vs-Social Drinker
2.174000E-01
Occasional Drinker-vs-Social Drinker
2.354200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.143800E-01
Normal-vs-Grade 2
6.115600E-02
Normal-vs-Grade 3
3.137600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.152100E-02
Grade 1-vs-Grade 3
4.551900E-02
Grade 1-vs-Grade 4
2.143800E-01
Grade 2-vs-Grade 3
8.034600E-01
Grade 2-vs-Grade 4
6.115600E-02
Grade 3-vs-Grade 4
3.137600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.128400E-01
Normal-vs-NonDiabetic
4.710600E-01
Diabetic-vs-NonDiabetic
1.158170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.292400E-01
Normal-vs-NoPancreatitis
5.265600E-01
Pancreatitis-vs-NoPancreatitis
7.541400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.008200E-01
Normal-vs-N1
4.821000E-01
N0-vs-N1
3.817200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.837610E-01
Normal-vs-TP53-NonMutant
7.197600E-01
TP53-Mutant-vs-TP53-NonMutant
1.025830E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
